Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
NCT ID: NCT04264234
Last Updated: 2022-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
98 participants
INTERVENTIONAL
2018-11-13
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Total Placenta Previa Associated With the Placenta Accreta Spectrum.
NCT06219564
EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA
NCT06849349
Low Implanted Second Trimester Placenta and Placenta Previa
NCT03431116
The Placental Thickness and Pregnancy Outcomes in Placenta Previa Women
NCT06717997
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
NCT03416296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placenta Previa
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography and MRI.
Vaginal Ultrasonography
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
Magnetic Resonance Imaging
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vaginal Ultrasonography
Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.
Magnetic Resonance Imaging
Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To apply before the 28th week
* To have a low-risk second trimester screening test
* No malformation detected in the anomaly screening
Exclusion Criteria
* Pregnancy complicated with preeclampsia
* Pregnancy complicated by gestational hypertension
* Pregnancy complicated by gestational diabetes mellitus
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sabahattin Anıl Arı
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sabahattin a Arı, MD
Role: PRINCIPAL_INVESTIGATOR
Ege University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University Hospital
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-9.1/27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.